Logiscreen

Boston Scientific Corp

$48.55
Market Cap 72.04B
ROE 14.9%
Gross Margin 69.4%
Debt/Equity 0.4
Current Ratio 1.9
Revenue QoQ 11.6%
EPS QoQ 1.0%
F-Score 5

About

Boston Scientific transforms lives through innovative medical technologies that improve the health of patients around the world. As a global medical technology leader for more than 45 years, we advance science for life by providing a broad range of high-performance solutions that address unmet patient needs and reduce the cost of healthcare. Our portfolio of devices and therapies helps physicians diagnose and treat complex cardiovascular, respiratory, digestive, oncological, neurological and urological diseases and conditions.

Exchange
NYSE
Sector
Healthcare
Industry
Medical Devices

Sector context

Healthcare

Undervalued

Trading at a discount to sector peers

P/E
20.33
vs median 33.61
P/B
2.80
vs median 2.16
ROE
0.15
vs median 0.09

Decent quality with acceptable fundamentals

Large-cap company with established market presence

Similar companies

Primary metric
Overlay metric
Loading chart data...
Fetching latest financial metrics